Cowen Financial Products LLC 13D and 13G filings for Stoke Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-26 10:38 am Purchase |
2023-12-29 | 13G | Stoke Therapeutics, Inc. STOK |
Cowen Financial Products LLC | 3,721,659 8.300% |
1,445,553 (+63.51%) |
Filing |
| 2024-02-26 10:36 am Purchase |
2023-01-04 | 13G | Stoke Therapeutics, Inc. STOK |
Cowen Financial Products LLC | 2,276,106 5.770% |
1,028,029 (+82.37%) |
Filing |
| 2023-01-25 3:45 pm Sale |
2022-12-30 | 13G | Stoke Therapeutics, Inc. STOK |
Cowen Financial Products LLC | 1,248,077 1.890% |
-623,452 (-33.31%) |
Filing |
| 2022-01-24 07:44 am Purchase |
2022-01-19 | 13G | Stoke Therapeutics, Inc. STOK |
Cowen Financial Products LLC | 1,871,529 5.090% |
1,871,529 (New Position) |
Filing |